ÂÜŔňÂŇÂ×

Dr. Ami Shah Brown is Senior Vice President of Regulatory Strategies at Inovio Pharmaceuticals, Inc. since May 2011. In this capacity, she is responsible for oversight of domestic and international regulatory affairs for Inovio’s prophylactic vaccines and immunotherapies in the fields of infectious disease and oncology. Formerly, she led operations, regulatory affairs, and quality assurance activities for the Sabin Vaccine Institute’s Vaccine Development division and served on the faculty of The George Washington University as an Assistant Professor in the Department of Microbiology, Immunology, and Tropical Medicine. Dr. Brown’s diverse academic and professional background also includes training and community work in support of various HIV vaccine trials at The Johns Hopkins School of Public Health’s Center for Immunization Research, a fellowship with the Centers for Disease Control and Prevention’s (CDC) National Centers for HIV, STD, and TB prevention (NCHSTP) to develop measures for behavioral surveillance, and with the Emory Vaccines Center. She received her PhD in International Health with a focus in vaccine development, application, and policy from The Johns Hopkins Bloomberg School of Public Health. She holds a Master of Public Health (MPH) degree from The Rollins School of Public Health of Emory University and a BA in Biology from the University of Pennsylvania.